Does ADALIMUMAB-AATY Cause Hypersensitivity? 26 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 26 reports of Hypersensitivity have been filed in association with ADALIMUMAB-AATY (Yuflyma). This represents 1.6% of all adverse event reports for ADALIMUMAB-AATY.
26
Reports of Hypersensitivity with ADALIMUMAB-AATY
1.6%
of all ADALIMUMAB-AATY reports
1
Deaths
4
Hospitalizations
How Dangerous Is Hypersensitivity From ADALIMUMAB-AATY?
Of the 26 reports, 1 (3.8%) resulted in death, 4 (15.4%) required hospitalization, and 1 (3.8%) were considered life-threatening.
Is Hypersensitivity Listed in the Official Label?
Yes, Hypersensitivity is listed as a known adverse reaction in the official FDA drug label for ADALIMUMAB-AATY.
What Other Side Effects Does ADALIMUMAB-AATY Cause?
Intentional dose omission (338)
Drug ineffective (151)
Intentional product use issue (151)
Death (132)
Arthralgia (96)
Rheumatoid arthritis (94)
Fatigue (92)
Therapy interrupted (88)
Crohn's disease (87)
Headache (86)
What Other Drugs Cause Hypersensitivity?
ETANERCEPT (10,846)
ADALIMUMAB (10,641)
METHOTREXATE (9,799)
TOCILIZUMAB (9,076)
ABATACEPT (8,945)
INFLIXIMAB (8,519)
RITUXIMAB (8,408)
ADAPALENE (8,356)
LEFLUNOMIDE (7,926)
CERTOLIZUMAB PEGOL (7,353)
Which ADALIMUMAB-AATY Alternatives Have Lower Hypersensitivity Risk?
ADALIMUMAB-AATY vs ADALIMUMAB-ADAZ
ADALIMUMAB-AATY vs ADALIMUMAB-ADBM
ADALIMUMAB-AATY vs ADALIMUMAB-AFZB
ADALIMUMAB-AATY vs ADALIMUMAB-ATTO
ADALIMUMAB-AATY vs ADALIMUMAB-BWWD